Login
$ABBV
$285.47 -$1.27 (0.44%) Live

Ownership

13F as of Q2 2026 · 1.77B shares outstanding

Who owns ABBV?

By type of holder
Institutions 75.2% Insiders 0.0% Everyone else 24.8%
Concentration Top 10 holders own 34.3%
BlackRock, Inc. 8.5% · Vanguard Capital Management LLC 6.5%
Institutional ownership
75.2%
+1.8 pts vs last qtr
Institutional holders
4,182
+105 vs last qtr
Net shares bought
+31.0M
by institutions in Q2 2026
New / sold out
288 / 183
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +25.6M
  • Jupiter Topco LLC NEW +6.2M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Jpmorgan Chase & Co −8.9M
  • Janus Henderson Group PLC SOLD OUT −6.9M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$21.7M
5 notices from 4 people
Shares covered
92.0K
0.01% of the company
Arranged in advance
44%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$4.1M$8.2MNovDecJanFeb 2026: $5.1M under a 10b5-1 planFebMar 2026: $4.4M under a 10b5-1 planMar 2026: $1.2M without a planMarAprMay 2026: $2.8M without a planMayJunJulAug 2026: $8.2M without a planAugSepOct
Largest proposed sellers
  • Perry C Siatis Officer 10b5-1 $9.52M
  • Nicholas Donoghoe Officer $8.18M

Sign up to see all 4.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+8.7%
+0.93% a year
Each share's claim on the business
−8.0%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$28.1B vs $6.3B
over 10 fiscal years
Diluted shares, split-adjusted
1.44B1.62B1.8B2016: 1.63B shares'162017: 1.6B shares'172018: 1.55B shares'182019: 1.48B shares'192020: 1.67B shares'202021: 1.78B shares'212022: 1.78B shares'222023: 1.77B shares'232024: 1.77B shares'242025: 1.77B shares'25
Buybacks Stock-based comp
$0$6.01B$12.01B2016 buybacks: $6.03B2016 stock comp: $353.0M'162017 buybacks: $1.41B2017 stock comp: $365.0M'172018 buybacks: $12.01B2018 stock comp: $421.0M'182019 buybacks: $629.0M2019 stock comp: $430.0M'192020 buybacks: $978.0M2020 stock comp: $753.0M'202021 buybacks: $934.0M2021 stock comp: $692.0M'212022 buybacks: $1.49B2022 stock comp: $671.0M'222023 buybacks: $1.97B2023 stock comp: $747.0M'232024 buybacks: $1.71B2024 stock comp: $911.0M'242025 buybacks: $980.0M2025 stock comp: $955.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years87% 3–5 years4% 1–3 years5% Under 1 year4%
Quarterly turnover
6.2%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting ABBV on Form 13F
B
BlackRock, Inc.
Shares
149.5M
% of company
8.46%
Change vs last qtr
−1.2M (−0.8%)
Held since
≤2021
VC
Vanguard Capital Management LLC
Shares
115.4M
% of company
6.53%
Change vs last qtr
+515.8K (+0.4%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding AbbVie Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ABBV on Form N-PORT; together they hold 28.7% of the company
VT
Position value
$14.1B
% of company
3.17%
% of the fund
0.61%
As of
June 30, 2026
V5
Vanguard Index Funds
Position value
$11.5B
% of company
2.59%
% of the fund
0.69%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding AbbVie Inc. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support